NCT03639090View on ClinicalTrials.gov

Mass Spectrometry in Single Bladder Cancer Cells

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

October 8, 2020

Study Completion Date

October 8, 2020

Conditions
Bladder Cancer
Interventions
DIAGNOSTIC_TEST

mass spectrometry

mass spectrometry for bladder cancer cells

Trial Locations (1)

73104

University of Oklahoma HSC, Department of Urology, Oklahoma City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Oklahoma

OTHER

NCT03639090 - Mass Spectrometry in Single Bladder Cancer Cells | Biotech Hunter | Biotech Hunter